Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CAPRICOR THERAPEUTICS, INC. | CHIEF EXECUTIVE OFFICER, Director | Common Stock | 199K | $276K | $1.39 | May 12, 2023 | Direct |
CAPRICOR THERAPEUTICS, INC. | CHIEF EXECUTIVE OFFICER, Director | Stock Option (Right to Buy) | 9.63K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | CHIEF EXECUTIVE OFFICER, Director |
CAPR | CAPRICOR THERAPEUTICS, INC. | May 12, 2023 | 2 | $28.8K | 4 | May 16, 2023 | CHIEF EXECUTIVE OFFICER, Director |
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | CHIEF EXECUTIVE OFFICER, Director |
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | CHIEF EXECUTIVE OFFICER, Director |